Vaccine Market

Canada's Microbix Biosystems is plotting a $200 million flu vaccine plant in Hunan province. The cooperative deal puts Microbix in partnership with the Hunan government, which will put up $100 million of the funding. The rest will come from Microbix's licensing partners. Report [1]

Supply constraints for an ingredient in a shingles vaccine has forced Merck to warn about looming shipping delays for Zostavax. Article [2]

Health officials in the U.S. are hoping that a new 5-in-1 vaccine will improve compliance on recommended vaccinations in the U.S. by reducing the complex number of vaccinations that are recommended. Story [3]

Canada's Bioniche Life Sciences says it has secured the financing necessary to scale-up its vaccine production facility. Story [4]

Vaccine Research

Insight into the unique immune system of intestines has helped advance an experimental bowel cancer vaccine, say researchers at the Kimmel Cancer Centre at Thomas Jefferson University. Article [5]

DynPort Vaccine has won the federal contract to develop a new plague vaccine. Story [6]

Medicago announced additional positive results for its H5N1 avian flu vaccine from a preclinical immunogenicity study performed in ferrets. Release [7]

The Albany Medical College has won a $5.4 million grant to work on a new universal flu vaccine. Report [8]